Ryan Crowe
Senior Vice President, Investor Relations
Replay available
Regeneron Pharmaceuticals, Inc. (REGN) Q2 2026 Earnings Call
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Q2 2026 earnings conference call, held 2026-07-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Leonard Schleifer
Co-founder, Board Co-Chair, President and Chief Executive Officer
Dr. George Yancopoulos
Co-founder, Board Co-Chair, President and Chief Scientific Officer
Marion McCourt
Executive Vice President, Commercial
Chris Fenimore
Executive Vice President, Finance and Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Regeneron Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.071 -- 00:00:05.433 Welcome to the Regeneron Pharmaceuticals second quarter 2026 earnings conference call. 00:00:05.433 -- 00:00:08.715 My name is Michelle, and I'll be your operator for today's call. 00:00:08.715 -- 00:00:11.716 At this time, all participants are in a listen-only mode. 00:00:11.716 -- 00:00:14.497 Later, we will conduct a question and answer session. 00:00:14.497 -- 00:00:17.278 Please note that this conference call is being recorded. 00:00:17.278 -- 00:00:21.840 I will now just turn the call over to Ryan Crowe, Senior Vice President, Investor Relations. 00:00:21.840 -- 00:00:24.100 You may begin. 00:00:24.962 -- 00:00:28.480 Thank you, Michelle. Good morning, good afternoon, and good evening to everyone listening 00:00:28.480 -- 00:00:31.782 around the world. Thank you for your interest in Regeneron, and welcome to our second 00:00:31.782 -- 00:00:36.745 quarter 2026 earnings conference call. An archive and transcript of this call will be 00:00:36.745 -- 00:00:42.189 available on the Regeneron Investor Relations website shortly after our call concludes. 00:00:42.189 -- 00:00:47.393 Joining me on today's call are Dr. Leonard Schleifer, co-founder, board, co-chair, 00:00:47.393 -- 00:00:50.034 president, and chief executive officer, Dr. 00:00:50.034 -- 00:00:55.843 George Yancopoulos, co-founder, board, co-chair, president, and chief scientific officer, 00:00:55.843 -- 00:01:00.927 Marion McCourt, Executive Vice President Commercial, and Chris Fenimore, Executive 00:01:00.927 -- 00:01:05.290 Vice President Finance and Chief Financial Officer. 00:01:05.290 -- 00:01:09.873 For our call today, Len will briefly review key second quarter performance drivers, highlight 00:01:09.873 -- 00:01:15.338 important upcoming pipeline catalysts, and ...